Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Observational studies suggest that metformin may reduce cancer risk by approximately one-third. We examined cancer outcomes and all-cause mortality in published randomised controlled trials (RCTs).

More information
Type

Journal article

Journal

Diabetologia

Publication Date

10/2012

Volume

55

Pages

2593 - 2603

Keywords

Adult, Aged, Diabetes Complications, Diabetes Mellitus, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Neoplasms, Randomized Controlled Trials as Topic, Risk Factors, Survival Rate